FDA Inspection 1254807 — Biomat USA
The FDA completed an inspection of Biomat USA on Nov 7, 2024 in Meridian, MS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Meridian, MS (United States)